|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.11 USD | -2.67% |
|
-3.26% | -8.19% |
| Capitalization | 7.38B 6.28B 5.82B 5.44B 10.14B 678B 10.75B 66.52B 26.41B 320B 27.69B 27.12B 1,165B | P/E ratio 2026 * |
37x | P/E ratio 2027 * | 31x |
|---|---|---|---|---|---|
| Enterprise value | 7.98B 6.79B 6.29B 5.88B 10.96B 733B 11.62B 71.93B 28.56B 346B 29.94B 29.32B 1,260B | EV / Sales 2026 * |
6.09x | EV / Sales 2027 * | 5.36x |
| Free-Float |
98.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: HealthEquity, Inc.
| 1 day | -2.67% | ||
| 1 week | -3.26% | ||
| Current month | -8.19% | ||
| 1 month | -10.31% | ||
| 3 months | -11.91% | ||
| 6 months | -13.65% | ||
| Current year | -8.19% |
| 1 week | 83.4 |  | 87.41 |
| 1 month | 82.74 | | 99.5 |
| Current year | 82.74 | | 99.5 |
| 1 year | 74.07 | | 116.65 |
| 3 years | 48.86 | | 116.65 |
| 5 years | 36.8 | | 116.65 |
| 10 years | 15.8 | | 116.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Cutler
CEO | Chief Executive Officer | 56 | 05/01/2025 |
James Lucania
DFI | Director of Finance/CFO | 47 | 30/07/2023 |
Elimelech Rosner
CTO | Chief Tech/Sci/R&D Officer | 69 | 28/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Neeleman
BRD | Director/Board Member | 58 | 31/10/2002 |
Evelyn Dilsaver
BRD | Director/Board Member | 71 | 31/07/2014 |
Robert Selander
CHM | Chairman | 75 | 29/09/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -2.29% | 13.28% | 253 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.67% | -3.26% | -20.48% | +46.51% | 7.38B | |
| +3.28% | +2.03% | +4.43% | +93.97% | 3,353B | |
| +2.23% | -4.22% | +120.63% | +2,315.95% | 395B | |
| -1.59% | -1.34% | -7.95% | +46.43% | 97.47B | |
| +0.39% | -0.71% | -0.99% | +78.57% | 86.31B | |
| -1.33% | -5.65% | +108.23% | +2,087.43% | 81.83B | |
| +1.59% | +2.77% | +7.14% | +86.99% | 72.72B | |
| -0.78% | -15.08% | +10.45% | +103.01% | 52.43B | |
| +1.92% | +0.57% | +30.71% | +130.54% | 44.55B | |
| +0.72% | -1.61% | -33.42% | -30.45% | 36.52B | |
| Average | +0.38% | -3.12% | +21.88% | +495.90% | 422.77B | |
| Weighted average by Cap. | +2.70% | -1.88% | +16.94% | +338.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.31B 1.12B 1.03B 966M 1.8B 120B 1.91B 11.82B 4.69B 56.89B 4.92B 4.82B 207B | 1.41B 1.2B 1.11B 1.04B 1.93B 129B 2.05B 12.68B 5.03B 61.05B 5.28B 5.17B 222B |
| Net income | 206M 175M 162M 152M 283M 18.93B 300M 1.86B 737M 8.94B 773M 757M 32.52B | 246M 209M 194M 181M 338M 22.61B 358M 2.22B 880M 10.67B 923M 904M 38.83B |
| Net Debt | 600M 510M 473M 442M 824M 55.13B 873M 5.41B 2.15B 26.03B 2.25B 2.2B 94.68B | 161M 137M 127M 119M 221M 14.79B 234M 1.45B 576M 6.98B 604M 591M 25.41B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 84.11 $ | -2.67% | 1,030,962 |
| 22/01/26 | 86.42 $ | +2.16% | 807,571 |
| 21/01/26 | 84.59 $ | +0.70% | 1,485,972 |
| 20/01/26 | 84.00 $ | -1.60% | 737,404 |
| 16/01/26 | 85.37 $ | -1.81% | 1,115,303 |
Delayed Quote Nasdaq, January 23, 2026 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HQY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition